EPI-X4

CAT:
804-HY-P10415-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
EPI-X4 - image 1

EPI-X4

  • Description:

    EPI-X4 (hSA408–423 peptide) is an antagonist for C-X-C motif chemokine receptor 4 (CXCR4) with IC50 of 8.6 μM. EPI-X4 blocks the CXCL12-mediated signaling, inhibits chemokine-mediated migration and invasion of leukemia cell. EPI-X4 exhibits anti-inflammatory activity in mouse model. EPI-X4 exhibits antiviral activity against CXCR4-tropic HIV with IC50 of 8.6 μM[1].
  • Product Name Alternative:

    HSA (408–423) peptide
  • UNSPSC:

    12352209
  • Target:

    CXCR
  • Type:

    Peptides
  • Related Pathways:

    GPCR/G Protein; Immunology/Inflammation
  • Applications:

    COVID-19-anti-virus
  • Field of Research:

    Cancer; Infection; Inflammation/Immunology
  • Assay Protocol:

    https://www.medchemexpress.com/epi-x4.html
  • Purity:

    99.21
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    O=C(N[C@@H](C(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H]([C@H](O)C)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](C(C)C)C(N2[C@@H](CCC2)C(N[C@@H](CCC(N)=O)C(N[C@@H](C(C)C)C(N[C@@H](CO)C(N[C@@H]([C@H](O)C)C(N3[C@@H](CCC3)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(C)C)N
  • Molecular Formula:

    C84H144N22O23
  • Molecular Weight:

    1830.18
  • References & Citations:

    [1]Zirafi O, et al., Discovery and characterization of an endogenous CXCR4 antagonist. Cell Rep. 2015 May 5;11 (5) :737-47.|[2]Kaiser, L. M., et al., (2021) . Targeting of CXCR4 by the Naturally Occurring CXCR4 Antagonist EPI-X4 in Waldenström's Macroglobulinemia. Cancers, 13 (4), 826.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
  • Scientific Category:

    Peptides
  • Clinical Information:

    No Development Reported
  • Isoform:

    CXCR4
  • CAS Number:

    930280-31-2